Back to Search
ERIC HSI, M.D.
M.D.
Anatomic Pathology Physician
NPI: 1619934817IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology Physician
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
2020-04716(NC)35073783H(OH)
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
75607(MN)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1990
Research & Publications (20)
Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia.
PMID 19648166·Haematologica·2010
4-observational
Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology.
PMID 19332430·J Histochem Cytochem·2009
7-preclinical
The role of biomarkers in the management of patients with lymphoma: promise versus reality.
PMID 19406721·Clin Lymphoma Myeloma·2009
8-other
T-cell lymphoma in the head and neck? Think about adult T-cell leukemia/lymphoma.
PMID 19235010·Leuk Lymphoma·2009
8-other
Age-related Epstein-Barr virus-associated lymphoproliferative disorder presenting as renal mass.
PMID 19592072·Urology·2009
5-case
Monoclonal antibodies against IREM-1: potential for targeted therapy of AML.
PMID 19440216·Leukemia·2009
7-preclinical
Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype.
PMID 19144386·Hum Pathol·2009
8-other
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma.
PMID 19672775·Leuk Lymphoma·2009
4-observational
Rapid resolution of GVHD after orthotopic liver transplantation in a patient treated with alefacept.
PMID 19470441·Blood·2009
5-case
Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR.
PMID 19608671·Haematologica·2009
5-case
UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.
PMID 18818701·Leukemia·2009
8-other
Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
PMID 18264083·Mod Pathol·2008
8-other
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.
PMID 19021050·Leuk Lymphoma·2008
3-trial
Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.
PMID 18798102·Leuk Lymphoma·2008
6-review
Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F.
PMID 18479730·Hum Pathol·2008
5-case
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.
PMID 18452103·Leuk Lymphoma·2008
8-other
CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma.
PMID 18451245·Clin Cancer Res·2008
7-preclinical
CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma).
PMID 18822062·J Cutan Pathol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1619934817
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 3
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile